Cannot provide additional Covaxin doses: Bharat Biotech informs Delhi Govt
New Delhi: Deputy Chief Minister Manish Sisodia on Wednesday said Covaxin maker Bharat Biotech has refused to provide "additional" vaccine doses to the Delhi government, a development that is likely to severely hamper the inoculation drive for people in the 18-44 age group.
The stock of Covaxin in Delhi has finished as a result around 100 vaccination centres set up in 17 schools have been closed, he said in an online press briefing.
"The Covaxin manufacturer has in a letter said that it cannot provide the Delhi government vaccines due to unavailability, under instruction of government officials concerned. It means that the central government is controlling supply of the vaccine," Sisodia said.
However, Joint Secretary in the Union Health Ministry Lav Agarwal on Tuesday denied that the Centre had any role to play in the purchase of vaccines by the states.
Sisodia accused the Centre of vaccine mismanagement and reiterated that exporting 6.5 crore doses to foreign countries was the "biggest mistake".
The Delhi government had ordered 67 lakh doses each of Covishield and Covaxin on April 26, the deputy chief minister said.
According to the Delhi government figures, it has received 1.5 lakh Covaxin and 4 lakh Covishield doses so far to vaccinate people in the 18-44 age group.
Till now, a total of 48.7 lakh doses of both the vaccines have been received for various categories of beneficiaries, it showed.
"I had already said exporting 6.5 crore doses to foreign countries was the biggest mistake. It would have been sufficient to vaccinate everyone in Delhi and Mumbai with two doses each," Sisodia added.
During the online briefing, he read the letter received from Bharat Biotech, which said "...we are making dispatches as per the directions of the government officials concerned. We therefore sincerely regret that we cannot make any additional supplies as required by you".
The letter written by Bharat Biotech Chairman and Managing Director Dr Krishna Ella, on May 11, to the Delhi government''s principal secretary (health and family welfare) also mentioned "unprecedented demand" of Covaxin.
Bharat Biotech''s letter referred to another note written to it by the Delhi government on May 7 regarding supply of Covaxin.
Delhi BJP spokesperson Harish Khurana said Bharat Biotech''s letter cited by Sisodia has "exposed" his claim that the city government ordered 67 lakh Covaxin doses on April 26.
"The reality is they wrote letter of intent to Bharat Biotech on April 26. Sisodia should disclose what the Delhi government wrote to Bharat Biotech in its May 7 letter," he said.
The deputy chief minister also said that the Centre should stop export of vaccines and share the vaccine formulae of the two manufacturers in the country with other companies for mass scale production.
He also urged the Union government to approve vaccines available in the international market for use in India, and direct states to vaccinate everyone within three months.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.